Exploring GLP-1 Agonists for Idiopathic Intracranial Hypertension

This chapter delves into the potential of GLP-1 receptor agonists in treating idiopathic intracranial hypertension, highlighting their effects on the nervous system and intracranial pressure reduction. The discussion emphasizes ongoing research, collaborative efforts, and the importance of rigorous testing to integrate these findings into clinical practice.